Literature DB >> 1159812

Relationship of tumor immunogenicity to concentration of the oncogen.

R T Prehn.   

Abstract

Tumors were induced sc in (BALB/c x DBA/2)F1 female mice by various concentrations of 3-methylcholanthrene (MCA) in paraffin pellets. There was an inverse relationship between MCA concentration and tumor latency (interval between MCA implantation and detection of gross tumor). The tumors were transplanted into syngeneic recipients, and material from this first transplant generation was used to immunize a series of syngeneic mice; any resulting growth was excised. Nonimmunized mice were controls. Immunized and control mice were irradiated and given an sc inoculation of a near-threshold number of tumor cells. Tumor growth from that inoculation was measured weekly in both groups and the antigenicity ratio (mean tumor size in controls/mean tumor size in immunized mice) was calculated. In a series of tumors with similar latencies, the only ones with high antigenicity ratios were those resulting from the high MCA concentration. The results suggested that tumors induced by low levels of oncogen may be good models of spontaneous neoplasia, strengthened the hypothesis that "spontaneous' tumors may actually result from low levels of oncogen, and indicated that neoplastic transformation and the development of immunogenicity are, at least in chemically induced tumors, independent changes that may be produced in the same cell when the concentration of oncogen is sufficient.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159812     DOI: 10.1093/jnci/55.1.189

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

Review 1.  Tumor immunogenicity: how far can it be pushed?

Authors:  R T Prehn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

2.  Tumour-associated antigens.

Authors:  R W Baldwin
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

3.  Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.

Authors:  A Van Pel; M Georlette; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

4.  Release of lymphotoxin by control and chemical carcinogen-treated lymphocyte cultures derived from black healthy subjects and cancer patients.

Authors:  L J Alfred; N Venkatesan; A K Mandal; G Gill; M Richardson; C Williams; C Bradley
Journal:  J Natl Med Assoc       Date:  1982-08       Impact factor: 1.798

5.  Specific immunoprophylaxis in experimental tumour-host systems.

Authors:  M D Prager; W C Gordon
Journal:  Can Med Assoc J       Date:  1980-04-05       Impact factor: 8.262

6.  Influence of immune status of host on immunogenicity of tumors induced with two doses of methylcholanthrene.

Authors:  E M Lawler; R T Prehn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.

Authors:  Nadia Guerra; Ying Xim Tan; Nathalie T Joncker; Augustine Choy; Fermin Gallardo; Na Xiong; Susan Knoblaugh; Dragana Cado; Norman M Greenberg; Norman R Greenberg; David H Raulet
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

Review 8.  An immune reaction may be necessary for cancer development.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-02-03       Impact factor: 2.432

9.  Multicellular origin of fibrosarcomas in mice induced by the chemical carcinogen 3-methylcholanthrene.

Authors:  A L Reddy; P J Fialkow
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  On the nature of cancer and why anticancer vaccines don't work.

Authors:  Richmond T Prehn
Journal:  Cancer Cell Int       Date:  2005-08-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.